PYPD: PolyPid Ltd. Stock

by  •  • Comments Off on PYPD: PolyPid Ltd. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 28.02
Enterprise Value ($M) 19.80
Book Value ($M) 7.68
Book Value / Share 0.75
Price / Book 3.65
NCAV ($M) -0.96
NCAV / Share -0.09
Price / NCAV -29.10

Profitability (mra)
Return on Invested Capital (ROIC) -1.68
Return on Assets (ROA) -1.14
Return on Equity (ROE) -4.06

Liquidity (mrq)
Quick Ratio 1.31
Current Ratio 1.31

Balance Sheet (mrq) ($M)
Current Assets 16.57
Assets 25.22
Liabilities 17.54
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -28.03
Net Income -29.02

Cash Flow Statement (mra) ($M)
Cash From Operations -21.96
Cash from Investing -0.33
Cash from Financing 32.42

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-03 13G/A Aurum Ventures M.k.i. Ltd. 19.80 -74.32
02-14 13G/A Centaurus Investments Ltd 19.90 254.63
02-14 13G/A Rosalind Advisors, Inc. 9.90
12-12 13G/A Lukach Aharon 7.70 15.42
11-29 13G/A Nir Yehuda 13.90 10.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 2,431 11,187 21.73
2025-04-24 6,613 24,795 26.67
2025-04-23 988 5,849 16.89
2025-04-22 884 3,516 25.14

(click for more detail)

Similar Companies
POCI – Precision Optics Corporation, Inc. PROF – Profound Medical Corp.
PSTV – Plus Therapeutics, Inc. RCEL – AVITA Medical, Inc.
RSLS – ReShape Lifesciences Inc.


Financial data and stock pages provided by
Fintel.io